News
Researchers to be honored at ASPHO
Hematology and oncology researchers will receive awards at the 2019 American Society of Pediatric Hematology/Oncology conference.
Video
Sorafenib plus GCLAM held safe in AML, MDS phase-1 study
NEWPORT BEACH, CALIF. – Sorafenib plus GCLAM has shown promise in a phase 1 trial of patients with AML and MDS.
Video
Study highlights lack of data on transgender leukemia patients
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
Video
ALF 2019 showcases evolving treatment of AML
NEWPORT BEACH, CALIF. – Dr. Martin Tallman discusses meeting presentations on the treatment of AML.
Video
Back to the drawing board for MPN combo
NEWPORT BEACH, CALIF. – Ruxolitinib plus decitabine won’t proceed to a phase 3 trial for the treatment of accelerated or blast phase...
Video
Creating CAR T-cell therapies for T-cell malignancies
NEWPORT BEACH, CALIF. – Dr. John F. DiPersio discusses preclinical research testing CAR T-cell therapies in T-cell malignancies.
News
SB-525 gene therapy looks viable for hemophilia A
Two of eight patients treated with the investigational gene therapy SB-525 have achieved normal factor VIII levels, according to interim study...
News
In situ vaccination produced responses in indolent NHL
In situ vaccination induced regression of tumors that were directly targeted, as well as tumors that were not treated, in a small study of...
Article
New leaders at SGO, AACR
Dr. Warner K. Huh is named president of the Society of Gynecologic Oncology, and appointments are made at AACR, NCCN, and MD Anderson.
News
Polatuzumab outperforms pinatuzumab in non-Hodgkin lymphoma
Polatuzumab vedotin plus rituximab produced more durable responses than did pinatuzumab vedotin plus rituximab in patients with relapsed or...
News
Combo could replace standard conditioning regimen for myeloma
The combination of busulfan plus melphalan produced superior progression-free survival but no overall survival advantage in the phase 3 trial.
News
Cancer researchers take home AACR honors
The researchers will be recognized at the annual meeting of the American Association for Cancer Research in Atlanta.
Article
Brachytherapy access may mediate poor cervical cancer survival in blacks
“This is the first study, to our knowledge, to show such an interaction between race and survival being mediated by one particular treatment...
News
Combo shows promise for endometrial, ovarian cancers
HONOLULU – Combination lenvatinib and paclitaxel produced an objective response rate of 65%, and most adverse events were grade 1 or 2.
News
Perceived cancer risk may improve access to HPV vaccine
HONOLULU – The perceived risk of HPV-related cancer appears to overcome variables that typically impede access to...